Cladribine

ADVERTISEMENT

Identification

Molecular formula
C10H12ClN5O3
CAS Number
4291-63-8
IUPAC Name
2-[2-chloro-6-(cyclopentylamino)purin-9-yl]-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
Molecular Weight
285.69g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
1.9108g/cm3
Synonyms
2-[2-chloro-6-(cyclopentylamino)-9-purinyl]-5-(hydroxymethyl)oxolane-3, 4-diol
Interesting facts

Interesting Facts about 2-[2-chloro-6-(cyclopentylamino)purin-9-yl]-5-(hydroxymethyl)tetrahydrofuran-3,4-diol

This compound is a fascinating member of the purine family, which is well-known for its roles as the building blocks of nucleic acids like DNA and RNA. The structural complexity of this compound can be attributed to its multiple functional groups, which bring about various chemical properties and biological activities.

Key Features:

  • Functional Diversity: The presence of both the purine structure and a tetrahydrofuran ring makes this compound unique. The hydroxymethyl group adds to its hydrophilicity, potentially impacting its interaction with biological systems.
  • Biological Relevance: Compounds like this often serve as important pharmacophores in medicinal chemistry, acting on specific biological targets. Its chlorinated derivative suggests that it may possess enhanced reactivity or biological activity, making it a candidate for further scientific exploration.
  • Potential Applications: The compound holds potential in the realm of therapeutic agents, particularly in the fields of oncology and virology, by potentially modulating cellular pathways or inhibiting viral replication.

As noted by researchers, “The structural modifications can greatly affect the compound's affinity for its target, leading to variations in efficacy.” This emphasizes the importance of understanding structural nuances in drug design and development.

Research Opportunities:

Given its unique attributes, there is ample room for research in the following areas:

  • Mechanism of Action: Detailed studies could reveal how this compound interacts at the molecular level with specific targets.
  • Structure-Activity Relationship (SAR): Investigating how modifications to the structure influence biological activity could yield valuable insights for designing new therapeutics.
  • Formulation Development: Understanding solubility and stability could lead to effective delivery systems for clinical applications.

In conclusion, 2-[2-chloro-6-(cyclopentylamino)purin-9-yl]-5-(hydroxymethyl)tetrahydrofuran-3,4-diol is not just a chemical compound; it represents a nexus of structural diversity and potential therapeutic utility that beckons further investigation. Its journey in the laboratory could unveil new frontiers in pharmacology and biochemistry.

ADVERTISEMENT